What is erythromelalgia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Erythromelalgia

Erythromelalgia is a rare, debilitating neurovascular pain disorder characterized by episodic burning pain accompanied by red, hot extremities (primarily feet and hands), with symptoms triggered by heat or exercise and relieved by cooling. 1

Clinical Presentation

The disorder presents with a characteristic triad:

  • Intense burning pain in the distal extremities
  • Erythema (redness) of affected areas
  • Increased warmth and sometimes swelling of the extremities

Episodes are typically triggered by:

  • Physical activity or exercise
  • Exposure to warm temperatures
  • Heat exposure
  • Stress

Patients characteristically seek relief through cooling measures, though this can lead to complications if done excessively (ice water immersion can cause tissue damage and ulcerations). 1

Pathophysiology

The underlying mechanism involves vasodilation of thermoregulatory arteriovenous anastomoses, likely representing a dysregulation of endogenous temperature control. 1 Recent pathology studies suggest this is a dysautonomia syndrome with vascular ectasia and denervation of eccrine coils and arteries, similar to small fiber neuropathy. 2

Classification

Primary (Inherited) Erythromelalgia

Approximately 5% of patients have a family history with autosomal dominant inheritance. 1 This form is caused by gain-of-function mutations in the SCN9A gene, which encodes Nav1.7 sodium channels in nociceptive sensory neurons. 1 These mutations cause sodium channels to open more easily and remain open longer, resulting in prolonged neuronal activation and explaining the disproportionate pain experienced during episodes. 1

Secondary Erythromelalgia

Associated with underlying conditions, most notably:

  • Myeloproliferative diseases (essential thrombocythemia, polycythemia vera) - approximately 5% of cases 1
  • Autoimmune conditions 2
  • Certain medications and toxins 3

Idiopathic Erythromelalgia

No identifiable cause or family history. 1

Important note: The distinction between primary and secondary forms does not substantially affect management. 1

Diagnostic Challenges

The diagnosis is frequently missed because symptoms are intermittent and extremities may appear completely normal during clinical examination. 1 Patients often self-diagnose before seeking medical attention. The diagnosis is primarily clinical, though genetic testing for SCN9A mutations can confirm primary forms when present (detected in only 19% of cases in recent studies). 4

Key differential diagnoses to exclude:

  • Complex regional pain syndrome
  • Cellulitis
  • Non-freezing cold injury
  • Small fiber neuropathies 3

Clinical Significance and Prognosis

This is not merely a quality-of-life issue - patients with erythromelalgia have significantly increased morbidity, mortality, and suicide risk compared to the general population. 1 The pain can be so severe that it fundamentally alters lifestyle, with patients avoiding normal activities and engaging in extreme cooling behaviors that can cause additional tissue damage. 1

Common Pitfalls

  • Missing the diagnosis due to normal examination between episodes - maintain high clinical suspicion based on history alone
  • Allowing harmful cooling behaviors - patients must be counseled that ice water immersion and continuous fan use can cause immersion foot, ulcerations, and windburn-like injury 1
  • Assuming all cases need genetic testing - only 19% have detectable SCN9A mutations, and testing doesn't change management 4
  • Failing to screen for myeloproliferative disease - this treatable secondary cause should be evaluated in all patients 1

Related Questions

What are the causes of erythromelalgia?
Who should we consult in neurology to confirm a diagnosis of erythromelalgia?
In a patient with suspected erythromelalgia, what is the significance of persistent small red spots that do not resolve when the burning pain and warmth subside, and what further evaluation is recommended?
What are the symptoms of erythromelalgia?
What is the recommended diagnostic and treatment approach for a patient with erythromyalgia presenting with persistent burning pain, warmth, and erythema of the muscles that worsens with heat and improves with cooling?
What is the recommended inpatient work‑up for an acute stroke patient?
What is the safest first‑line antidepressant for a patient with a corrected QT interval of 580 ms, depression, alcohol use disorder, and a seizure disorder?
What treatment recommendations are appropriate for a patient with severe hypoalbuminemia (albumin 1.7 g/dL), near‑normal aspartate aminotransferase (AST 4.8 U/L), elevated alanine aminotransferase (ALT 72 U/L) and alkaline phosphatase 146 U/L?
What is the appropriate management for lower extremity edema in a patient with liver cirrhosis?
After completing oral vancomycin therapy for Clostridioides difficile infection, how long should I wait before initiating prednisone for lower back pain?
In a 58-year-old female with rheumatoid arthritis, cervical osteoarthritis, hyperlipidemia, hypertension (blood pressure 137/75 mmHg), and mild proteinuria (24‑hour urine protein 221 mg), currently taking eplerenone (Inspra) 25 mg, amlodipine 5 mg, and nebivolol (Bystolic) 10 mg who has headaches and a recent retinal vein rupture without vision changes, what is the next step in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.